🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Closing Keynote ICOD 2: CADeN Public Awareness Committee member Georges Marcoux & Dr. David Gardner share the outcomes of a direct-to-patient initiative to promote #deprescribing among long-term sleeping pill users in New Brunswick, Canada. An impactful, scalable strategy

Congratulations to our PhD trainee, Altea Kthupi, on her first international conference talk at the International Conference on Deprescribing in Nantes, France! Pictured here: Kieran Dalton, Altea Kthupi, Lisa McCarthy (she/her) 🇨🇦 ICOD 2, #ICOD2 deprescribing.org

Thank you ICOD 2🇫🇷 for allowing virtual participation! I felt I could equally contribute during the workshops from 🇦🇺as much as those who attended in person! #deprescribing

Deprescribed or discontinued? One the this morning’s workshops by Caroline Sirois, Alexandre Campeau-Calfat and Justin Turner 🤓

Day 2 kicks of ICOD 2 with Aili Langford from #SydneyPharmacySchool discussing #deprescribing recommendations within guidelines!

Great workshop ICOD 2 from Caroline Sirois and @ACCalfat on defining deprescribing vs discontinuing. Exciting to hear billing codes being introduced for this in Quebec! #icod2 #icod2024

🍽 About last night... Australian representatives from ADeN connecting and collaborating with international #deprescribing researchers! Aili Langford Danijela Gnjidic Justin Turner Shin Liau @MikeSteinman US Deprescribing Research Network (USDeN) ICOD 2

Fun times on Day 2 ICOD 2 untangling webs of #prescribingcascades with a great group + leading minds Kieran Dalton 🇮🇪, Fatma Karapinar 🇳🇱 at #ICOD2!

Appreciate the opportunity to share this HealthResearchBoard funded work and the great discussion on what role stringent policy could/should play in deprescribing ICOD 2

@KatharinaJungo from Brigham and Women's Hospital presents team from Universität Bern BIHAM's mixed methods study focused on digital tools for primary care in 🇨🇭 at #ICOD2. A rising 🌟 in our #deprescribing field! ICOD 2

This afternoon sees the closing keynote ICOD 2 delivered by Frank Moriarty together with Anne Spinewine from @UCLouvain_be, reflecting on the excellent work presented over the past 2 days & future direction for research on #deprescribing.

Development and implementation of interprofessional deprescribing activities in LTCs, lets talk about the SimpleID project 😚

Everybody, let’s share some deprescribing interventions experienced all over the world 🌍 ! #oralcommunications Justin Turner

CADeN is grateful to have participated in ICOD 2, a rare occasion to regroup #deprescribing leaders from around the world! Many familiar faces mixed in with new connections – we’re eager to see how our global efforts shape deprescribing by the next edition of ICOD 🌟

Aaaaaand CUT! Frank Moriarty and Anne Spinewine are wrapping up ICOD2 with a keynote full of future insights on deprescribing, inspired by everyone’s hard work. ⏮️🚶🏼‍♂️‍➡️🚶🏼‍♀️‍➡️⏭️

The organizing committee is sad to let you go, but happy that everything went well! See you in 2 years, friends 🥰

Are you planning to submit any #deprescribing or deprescribing-related research soon? Look no further! 🎉 Basic & Clinical Pharmacology & Toxicology is hosting a Special Issue to provide a platform for deprescribing research! More information 👉 onlinelibrary.wiley.com/doi/toc/10.111…